Maple syrup urine disease definition

Maple syrup urine disease means a congenital disorder of branched chain amino acid metabolism due to defective branched chain-keto acid dehydrogenase activity.
Sample 1Sample 2Sample 3
Maple syrup urine disease means an inherited error in the metabolism of leucine, isoleucine, and valine.
Sample 1Sample 2Sample 3
Maple syrup urine disease. (MSUD) means deficiency of enzymes necessary to breakdown the branch chained amino acids leucine, isoleucine, and valine resulting in a buildup of these and metabolic intermediates in the blood. If undetected and untreated may result in mental and physical retardation or death.
Sample 1Sample 2Sample 3

Examples of Maple syrup urine disease in a sentence

  • Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.

  • Amino acidemias GeneralBesides Hyperphenylalaninemia/Phenylketonuria a range of other amino acidemias are screened for using ms/ms technology, such as Argeninemia, Argininosuccinic aciduria, Citrullinemia, type I and type II, Homocystinuria, Hypermethioniemias type I, III, Maple syrup urine disease and Tyrosinemias type I-III.

  • Minimum observation period of three months o Nodular regenerative hyperplasia: Indications similar to end-stage cirrhotic liver disease o Hereditary haemorrhagic telangiectasia o Glycogen storage disease o Primary hyperoxaluria o Ornithine transcarbamylase deficiency o Maple syrup urine disease o Porphyria o Amyloidosis – other * UKELD score less than 49 is required • A variant syndrome in the context of chronic liver disease.

  • Minimum observation period of three months o Nodular regenerative hyperplasia: Indications similar to end-stage cirrhotic liver disease o Hereditary haemorrhagic telangiectasia o Glycogen storage disease o Primary hyperoxaluria o Ornithine transcarbamylase deficiency o Maple syrup urine disease o Porphyria o Amyloidosis – other * UKELD score less than 49 is required  A variant syndrome in the context of chronic liver disease.

  • United States Army Corps of Eng’rs, 384 F.3d 1163, 1170 (9th Cir.

  • Maple syrup urine disease: Further evidence that newborn screening may fail to identify variant forms.

  • The following tests are covered only if they meet the criteria in section A above AND the specified situations: CPT 81205, BCKDHB (branched-chain keto acid dehydrogenase E1, beta polypeptide) (eg, Maple syrup urine disease) gene analysis, common variants (eg, R183P, G278S, E422X): Cover only when the newborn screening test is abnormal and serum amino acids are normal Diagnostic testing for cystic fibrosis (CF) CFTR, cystic fibrosis transmembrane conductance regulator tests.

  • Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.

  • Maple syrup urine disease - treatment and outcome in patients of Turkish descent in Germany.

  • If undetected and untreated may cause thromboembolism, mental and physical disabilities.(10) "Maple syrup urine disease" (MSUD) means defi- ciency of enzymes necessary to breakdown the branch chained amino acids leucine, isoleucine, and valine resulting in a buildup of these and metabolic intermediates in the blood.


More Definitions of Maple syrup urine disease

Maple syrup urine disease or “M.S.U.D.” means a congenital metabolic disorder of branch branched chain amino acid metabolism which causes mental retardation or death if not treated early in life due to defective branched chain- keto acid dehydrogenase activity.
Sample 1
Maple syrup urine disease means an inherited error in the metabolism of leucine, isoleucine, and valine. "MCH" (17) "MCH/CSHCS clinics" means clinics affiliated with the children's special health care services program of the division of maternal and child health of the department that provide services to women, children, and children with special health care needs.
Sample 1
Maple syrup urine disease or "M.S.U.D." means a congenital metabolic disorder of branch chain amino acid metabolism which causes mental retardation or death if not treated early in life.
Sample 1

Related to Maple syrup urine disease

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Terminal disease means an incurable and irreversible disease that has been medically confirmed and will, within reasonable medical judgment, produce death within six months.

  • Cannabinoid edible means food or potable liquid into which a cannabinoid concentrate, cannabinoid extract or dried marijuana leaves or flowers have been incorporated.

  • Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related

  • Flexible vinyl adhesive means an aerosol adhesive designed to bond flexible vinyl to substrates. Flexible vinyl means a nonrigid polyvinyl chloride plastic with at least five percent, by weight, of plasticizer content. A plasticizer is a material, such as a high boiling point organic solvent, that is incorporated into a vinyl to increase its flexibility, workability, or distensibility, and may be determined using ASTM Method E260-91 or from product formulation data.

  • Biological safety cabinet means a containment unit suitable for the preparation of low to moderate risk agents where there is a need for protection of the product, personnel, and environment, according to National Sanitation Foundation (NSF) Standard 49.

  • Mist spray adhesive means any aerosol which is not a special purpose spray adhesive and which delivers a particle or mist spray, resulting in the formation of fine, discrete particles that yield a generally uniform and smooth application of adhesive to the substrate.

  • sickle cell disease means a hemolytic disorder characterized by chronic anemia, painful events, and various complications due to associated tissue and organ damage; "hemolytic" refers to the destruction of the cell membrane of red blood cells resulting in the release of hemoglobin.

  • Designated chemical dependency specialist means a person

  • Iatrogenic infertility means an impairment of fertility by surgery, radiation, chemotherapy, or other medical treatment affecting reproductive organs or processes.

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Cannabinoid extract means a substance obtained by separating cannabinoids from marijuana by:

  • muscular dystrophy means a group of hereditary genetic muscle disease that weakens the muscles that move the human body and persons with multiple dystrophy have incorrect and missing information in their genes, which prevents them from making the proteins they need for healthy muscles. It is characterised by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue;

  • External beam radiation therapy means therapeutic irradiation in which the source of radiation is at a distance from the body.

  • Infection means the entry and development or multiplication of an infectious agent in the body of humans and animals that may constitute a public health risk;

  • Moving beam radiation therapy means radiation therapy with any planned displacement of radiation field or patient relative to each other, or with any planned change of absorbed dose distribution. It includes arc, skip, conformal, intensity modulation and rotational therapy.

  • Occupational disease means a disease contracted in the course of employment, which by its causes and the characteristics of its manifestation or the condition of the employment results in a hazard which distinguishes the employment in character from employment generally, and the employment creates a risk of contracting the disease in greater degree and in a different manner from the public in general.

  • Polystyrene foam adhesive means an aerosol adhesive designed to bond polystyrene foam to substrates.

  • Infectious Disease means an illness that is capable of being spread from one individual to another.

  • Chemical dependency means the physiological and psychological addiction to a controlled drug or substance, or to alcohol. Dependence upon tobacco, nicotine, caffeine or eating disorders are not included in this definition.

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • Substance use disorder means a cluster of cognitive,

  • Non-Administrator Substance Use Disorder Treatment Facility means a Substance Use Disorder Treatment Facility that does not meet the definition of an Administrator Substance Use Disorder Treatment Facility.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Therapeutic interchange means an authorized exchange of therapeutic alternate drug products in accordance with a previously established and approved written protocol.